(HealthDay)—For patients with type 2 diabetes, absent dorsalis pedis and/or posterior tibial pulses are associated with increased risk of major vascular outcomes, according to a study published online Sept. 27 in Diabetes ...
Oct 4, 2016
0
0
(HealthDay)—For women with diabetes who are using hormonal contraception, the absolute risk of thromboembolism is low, with the lowest rates seen with use of intrauterine and subdermal contraceptives, according to a study ...
Dec 6, 2016
0
0
(HealthDay)—For hospitalized patients, additional sleep and increased sleep efficiency correlate with lower odds of hyperglycemia and impaired fasting glucose, according to research published online Nov. 30 in Diabetes ...
Dec 8, 2016
0
0
(HealthDay)—Reduced baseline levels of circulating CD34+ stem cells predict adverse cardiovascular outcomes for patients with type 2 diabetes, according to a study published online Nov. 4 in Diabetes Care.
Nov 10, 2016
0
0
(HealthDay)—Resveratrol supplementation does not improve hepatic or peripheral insulin sensitivity among patients with type 2 diabetes, according to a study published online Oct. 7 in Diabetes Care.
Oct 24, 2016
0
3
(HealthDay)—For patients with type 2 diabetes, vildagliptin lowers blood pressure (BP) and elevates heart rate (HR), while metformin increases HR with no effect on BP during intraduodenal (ID) glucose infusion, according ...
Mar 8, 2017
0
11
(HealthDay)—Apparent diabetes treatment failures may in fact be attributable to nonadherence, according to a study published online Sept. 15 in Diabetes Care.
Sep 23, 2017
0
4
Strokes and heart attacks are rare for women with diabetes who use hormonal contraception, with the safest options being intrauterine devices (IUDs) and under-the-skin implants, new research published in Diabetes Care shows.
Dec 15, 2016
0
0
Smart phone apps could offer patients with type 2 diabetes a highly effective method of self-managing their condition, concludes a study by Cardiff University.
Oct 27, 2016
0
3
(HealthDay)—For patients with type 2 diabetes, saxagliptin is associated with improvement in the albumin/creatinine ratio (ACR), according to a study published online Oct. 17 in Diabetes Care.
Oct 25, 2016
0
0
